Used in Patients Receiving Anticoagulant Therapy (e.g., Rivaroxaban or Apixaban, Inhibitors of Coagulation Factor Xa) Who Require Reversal of Anticoagulation
1 clinical trials · Condition
| Record | Firm | Date |
|---|---|---|
| Phase I Study of MT1011 Injection in Healthy Subjects (NCT07024160) | Shaanxi Micot Pharmaceutical Technology Co., Ltd. | 2025-06-25 |
Track Used in Patients Receiving Anticoagulant Therapy (e.g., Rivaroxaban or Apixaban, Inhibitors of Coagulation Factor Xa) Who Require Reversal of Anticoagulation automatically
Every clearance here is in the API, with alerts when new ones post.